The Medicine Maker 2018 Innovation Awards
June 14, 2018
Nominations for the 2018 Innovation Awards are open!
1 min read
June 2018
Welcome to the June issue. Upfront investigates an FDA crackdown on unproven stem cell clinics and concerns that post-Brexit border delays could turn the UK into a “second tier state for pharmaceutical imports.” Phil Morton makes the argument for Albumin in “In My View,” while our cover feature looks at the three frontrunners of The Medicine Maker 2017 Innovation Awards. In Best Practice, we explore plastic recycling in biopharma manufacturing and the upcoming serialization deadlines; and in Profession, Valarie Higgins from Almac discusses how clinical trials have evolved over the years. We also Sit Down With Ajaz Hussain, President, National Institute for Pharmaceutical Technology and Education, Minnesota, USA.
Ahead of the Curve
June 13, 2018
Sitting Down With... Ajaz Hussain,President, National Institute for Pharmaceutical Technology and Education, Minnesota, USA.
1 min read
Coping With the Complex Clinical Trial Landscape…
June 13, 2018
Valarie joined the Almac Group 20 years ago after working as a clinical trial monitor. Today, she is President and Managing Director of the company’s Clinical Technologies business unit. Valarie discusses how clinical trials have evolved over the years and the key lessons she has learned while building her career in the industry.
1 min read
Manufacture
Packaging
Outsourcing
Regulation & Standards
Business & Trends
Facilities & Equipment
Technology & Manufacturing
Track & Chase
June 13, 2018
Serialization deadlines will shortly be upon us – but, rather than entering into a blind panic, consider the long term.
1 min read
From Single-Use to Re-Use
June 13, 2018
Even plastic used for biopharma manufacturing can be recycled, if we put our minds to it.Even plastic used for biopharma manufacturing can be recycled, if we put our minds to it.
1 min read
Intensify, Connect, and Continue
June 13, 2018
Thanks to the emergence of intensified and connected processes, the path to continuous biopharma manufacturing is open...Thanks to the emergence of intensified and connected processes, the path to continuous biopharma manufacturing is open...
1 min read
Boosting mAb Manufacture
June 13, 2018
mAbs are an important growth area forthe biopharma industry – so we need more effective purification technologies.
1 min read
Looking to a New Reality
June 13, 2018
Digital twins can have a big impact on pharma lab and facility design by allowing concepts to be rapidly created – and viewed in virtual and mixed reality.
1 min read
The Winning Formula
June 13, 2018
Meet the three frontrunners of The Medicine Maker 2017 Innovation Awards – spanning influenza vaccine development, a virtual reality space, and a way to boost monoclonal antibody manufacturing. Is there a recipe for success?
1 min read
Driving Quality in Injectables
June 13, 2018
As we meet increasing demand and satisfy trends towards self-administration in the injectables market, patient safety must remain the primary driver for innovation.
1 min read
The Argument for Albumin
June 13, 2018
Products are becoming increasingly complex and we need to get better at recognizing the strategies with the best advantages.
1 min read
ADCs Assemble
June 13, 2018
Antibody drug conjugates have not yet lived up to their potential, but there is hope – if we turn to the right solutions and techniques.
1 min read
Trials of a Medicine Maker
June 13, 2018
Convincing the Chief Technology Officer of the benefits of new technology.
1 min read
Poles Apart
June 13, 2018
A generic and inexpensive way to seperate chiral molecules: magnets
1 min read
American Patients First?
June 13, 2018
Will President Trump’s prices plan deliver for America’s patients?
1 min read
Style Over Substance
June 13, 2018
Pharma TV ads are getting longer, less humorous and more nostalgic – while containing fewer facts
1 min read
AI Picks Parkinson’s
June 13, 2018
Could artificial intelligence help repurpose old drugs for sufferers of the degenerative disorder?
1 min read
Hold Me Closer, UK Pharma: 2.0
June 13, 2018
Concerns abound that post-Brexit border delays could turn the UK into a “second tier state for pharmaceutical imports”
1 min read
FDA Quackdown
June 13, 2018
Regulators step in to stop stem cell clinics from marketing unproven therapies
1 min read
Facing the Good Problems
June 13, 2018
The cell therapy industry faces a number of complex problems. Fortunately, they are good problems to have.
1 min read
